RU94013606A - Hemostimulator - Google Patents

Hemostimulator

Info

Publication number
RU94013606A
RU94013606A RU94013606/14A RU94013606A RU94013606A RU 94013606 A RU94013606 A RU 94013606A RU 94013606/14 A RU94013606/14 A RU 94013606/14A RU 94013606 A RU94013606 A RU 94013606A RU 94013606 A RU94013606 A RU 94013606A
Authority
RU
Russia
Prior art keywords
blood
hemodepression
cytostatics
regeneration
drug
Prior art date
Application number
RU94013606/14A
Other languages
Russian (ru)
Other versions
RU2088249C1 (en
Inventor
Е.Д. Гольдберг
А.М. Дыгай
В.В. Жданов
И.А. Хлусов
П.А. Любавина
В.Е. Гольдберг
Е.В. Новицкий
В.И. Литвиненко
Т.П. Попова
Original Assignee
Научно-исследовательский институт фармакологии Томского научного центра РАМН
Filing date
Publication date
Application filed by Научно-исследовательский институт фармакологии Томского научного центра РАМН filed Critical Научно-исследовательский институт фармакологии Томского научного центра РАМН
Priority to RU94013606A priority Critical patent/RU2088249C1/en
Priority claimed from RU94013606A external-priority patent/RU2088249C1/en
Publication of RU94013606A publication Critical patent/RU94013606A/en
Application granted granted Critical
Publication of RU2088249C1 publication Critical patent/RU2088249C1/en

Links

Claims (1)

Лекарственное средство, стимулирующее регенерацию кроветворения при гемодепрессии, вызванной введением 5-фторурацила, относится к медицине, конкретно к клинической гематологии, и может быть использовано для фармакологической коррекции нарушений в системе крови, вызванных цитостатиками. Цель изобретения - снижение токсического действия цитостатиков на гемопоэз за счет стимуляции его регенерации. Сущность способа заключается в применении известного лекарственного препарата глицирама по новому назначению в качестве средства, стимулирующего восстановление кроветворения при цитостатических гемодепрессиях.Drug that stimulates the regeneration of blood during hemodepression caused by the introduction of 5-fluorouracil, refers to medicine, specifically to clinical hematology, and can be used for the pharmacological correction of disorders in the blood system caused by cytostatics. The purpose of the invention is to reduce the toxic effect of cytostatics on hematopoiesis due to the stimulation of its regeneration. The essence of the method lies in the application of a known drug glycyram for a new purpose as a means of stimulating the restoration of blood formation during cytostatic hemodepression.
RU94013606A 1994-04-18 1994-04-18 Hemostimulating agent RU2088249C1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
RU94013606A RU2088249C1 (en) 1994-04-18 1994-04-18 Hemostimulating agent

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
RU94013606A RU2088249C1 (en) 1994-04-18 1994-04-18 Hemostimulating agent

Publications (2)

Publication Number Publication Date
RU94013606A true RU94013606A (en) 1995-12-27
RU2088249C1 RU2088249C1 (en) 1997-08-27

Family

ID=20154837

Family Applications (1)

Application Number Title Priority Date Filing Date
RU94013606A RU2088249C1 (en) 1994-04-18 1994-04-18 Hemostimulating agent

Country Status (1)

Country Link
RU (1) RU2088249C1 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2423142C1 (en) 2009-12-02 2011-07-10 Общество С Ограниченной Ответственностью "Парафарм" Medication for treatment and prevention of urogenital system diseases in males

Similar Documents

Publication Publication Date Title
EA200000468A1 (en) THERAPEUTIC COMPOSITION FOR THE ADMINISTRATION OF TOLTERODINE WITH CONTROLLED DELIVERY
DE69230112T2 (en) ADVANCED DRUG DELIVERY SYSTEM AND METHOD FOR TREATING PSYCHIATRIC, NEUROLOGICAL AND OTHER DISEASES WITH CARBAMAZEPINE
DE69333321D1 (en) Use of a consensus interferon to reduce the side effects in the interferon treatment of viral hepatites.
ATE153856T1 (en) COMPOSITION FOR STIMULATING THE IMMUNE SYSTEM
RU94016393A (en) PEPTIDES possessing the ability to stimulate the growth of the growth hormone, method of production, pharmaceutical composition, method of treatment
PT740650E (en) CO-DRUGS AS A METHOD OF CONTROLLED DRUG ADMINISTRATION
RU95113492A (en) THERAPEUTIC COMBINATION CONTAINING THE HUMAN INTERFERON, ITS APPLICATION, PHARMACEUTICAL DRUG, PACKAGING AND METHOD OF TREATMENT
Steiner et al. Pentazocine-induced myopathy
RU95101385A (en) Products containing g-csf and tnf-binding protein
RU94013606A (en) Hemostimulator
DE69929616D1 (en) OXYHUMIC ACID AND ITS USE FOR THE TREATMENT OF DIFFERENT DISORDER
RU2003113987A (en) METHOD FOR TREATMENT AND PREVENTION OF DISEASES BY EXPOSURE TO BIOLOGICALLY ACTIVE POINTS AND ZONES
FR2786699B1 (en) MEDICINE, IN PARTICULAR FOR PREVENTING OR TREATING SEXUAL DYSFUNCTIONS
RU93016030A (en) A MEDICINE STIMULATING THE GRANULOSITARY GROWTH OF HEMATOPHONYA IN CYTOSTATIC MYELODEPRESSIONS
RU92013625A (en) DRUGS, STIMULATING ERYTHROID GROWTH BLOOD DURING CYTOSTATIC MYELOPRESSIONS
RU95113855A (en) METHOD FOR CONSERVATIVE TREATMENT OF EYE BURNS
SU1261662A1 (en) Method of treatment of syndrome of anterior scalene muscle
ATE291919T1 (en) USE OF ADATANSERIN FOR THE TREATMENT OF ACUTE NEURODEGENERATIVE DISEASES
RU93034376A (en) DRUG STIMULATING ERYTHROID AND GRANULOCITARY HEMORRHAGE GROWTH DURING CYTOSTATIC MYELODEPRESSIONS
RU95102718A (en) Method of immune status correction in hiv-infected patients
RU97111543A (en) METHOD FOR TREATING NEUROLOGICAL DISORDERS RELATED TO THE CHRONIC FORM OF CONGENITAL VIRAL INFECTION
UA29910A (en) A METHOD OF TREATMENT OF DYSFUNCTION OF THE PARTIAL-LOWER-JAW JOINT
MD1469G2 (en) Method of treatment of the burn shock
RU98110897A (en) METHOD FOR IMMUNOTHERAPY OF CHRONIC INFLAMMATORY DISEASES
RU93037848A (en) METHOD OF TREATMENT OF LEPROI PATIENTS